Decrease G1 phase, increase G2/M phase, induce apoptosis by down-regulating Bcl-2 and activating MAPK and affecting PI3K/AKT pathways, increase levels of IL-12, IFN-γ and TNF-α level in the host, suppress tumor invasion and metastasis. The gene discussed is BCL2; the disease is neoplasm.